CRISPR THERAPEUTICS AG
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $1.83B
Liabilities Breakdown FY2020
Total Liabilities: $163.7M
Asset Breakdown
Total Assets: $1.83B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.17B | 63.9% |
| Accounts Receivable | $144.0K | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $42.2M | 2.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $180.0K | 0.0% |
| Other Assets | $616.9M | 33.7% |
Liabilities Breakdown
Total Liabilities: $163.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.1M | 5.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $154.6M | 94.4% |